SI9520096A - Derivati 2,7-substituiranega oktahidro-1H-pirido /1,2-a/ pirazina - Google Patents

Derivati 2,7-substituiranega oktahidro-1H-pirido /1,2-a/ pirazina Download PDF

Info

Publication number
SI9520096A
SI9520096A SI9520096A SI9520096A SI9520096A SI 9520096 A SI9520096 A SI 9520096A SI 9520096 A SI9520096 A SI 9520096A SI 9520096 A SI9520096 A SI 9520096A SI 9520096 A SI9520096 A SI 9520096A
Authority
SI
Slovenia
Prior art keywords
pyrido
octahydro
pyrazine
methyl
mmol
Prior art date
Application number
SI9520096A
Other languages
English (en)
Slovenian (sl)
Inventor
Kishor A. Desai
Anton F.J. Fliri
Mark A. Sanner
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SI9520096A publication Critical patent/SI9520096A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9520096A 1994-09-30 1995-08-24 Derivati 2,7-substituiranega oktahidro-1H-pirido /1,2-a/ pirazina SI9520096A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31547094A 1994-09-30 1994-09-30
PCT/IB1995/000689 WO1996010571A1 (en) 1994-09-30 1995-08-24 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES

Publications (1)

Publication Number Publication Date
SI9520096A true SI9520096A (sl) 1998-04-30

Family

ID=23224581

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520096A SI9520096A (sl) 1994-09-30 1995-08-24 Derivati 2,7-substituiranega oktahidro-1H-pirido /1,2-a/ pirazina

Country Status (34)

Country Link
US (1) US5852031A (es)
EP (1) EP0783503B1 (es)
JP (1) JP3287574B2 (es)
KR (1) KR100244848B1 (es)
CN (1) CN1068327C (es)
AT (1) ATE209648T1 (es)
AU (1) AU681310B2 (es)
BR (1) BR9504230A (es)
CA (1) CA2200959C (es)
CO (1) CO4410335A1 (es)
CZ (1) CZ285090B6 (es)
DE (1) DE69524241T2 (es)
DK (1) DK0783503T3 (es)
ES (1) ES2166830T3 (es)
FI (1) FI113655B (es)
HR (1) HRP950507B1 (es)
HU (1) HUT77354A (es)
IL (1) IL115384A (es)
MX (1) MX9702350A (es)
MY (1) MY113729A (es)
NO (1) NO308995B1 (es)
NZ (1) NZ290936A (es)
PE (1) PE47196A1 (es)
PL (1) PL180899B1 (es)
PT (1) PT783503E (es)
RU (1) RU2163239C2 (es)
SI (1) SI9520096A (es)
SK (1) SK284341B6 (es)
TR (1) TR199501194A2 (es)
TW (1) TW406081B (es)
UA (1) UA50720C2 (es)
WO (1) WO1996010571A1 (es)
YU (1) YU63795A (es)
ZA (1) ZA958223B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US6992188B1 (en) 1995-12-08 2006-01-31 Pfizer, Inc. Substituted heterocyclic derivatives
RU2162470C2 (ru) * 1995-12-21 2001-01-27 Пфайзер Инк. 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения
US6281216B1 (en) * 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
EP0953567A3 (en) 1998-04-29 2003-04-02 Pfizer Products Inc. Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
GT199900060A (es) * 1998-05-22 2000-10-14 Polimorfos de un monoclorhidrato de pirazina cristalino y sus composiciones farmacèuticas.
GB0010757D0 (en) 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
GB0011013D0 (en) * 2000-05-09 2000-06-28 Astrazeneca Ab Chemical compounds
EP1177792A3 (en) 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
GB0121941D0 (en) 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
EP0173634B1 (fr) * 1984-08-07 1988-08-31 Cortial S.A. Nouveaux dérivés d'(arylpipérazinyléthylaminoéthoxy)-4 phénol, leur méthode de préparation et leur application thérapeutique
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
ES2072141T3 (es) * 1991-01-31 1995-07-01 Pfizer Resolucion de trans-2-(2-pirimidinil)-7-(hidroximetil)octahidro-2h-pirido(1,2a)pirazina.
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
DE69218414T2 (de) * 1991-02-27 1998-01-22 Pfizer Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
HUT71488A (en) * 1991-09-25 1995-11-28 Pfizer Process for the production of neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines and pharmaceuticals compositions containing the same
US5719286A (en) * 1992-06-16 1998-02-17 Pfizer Inc. Process and intermediates for bis-aza-bicyclic anxiolytic agents
CA2146018A1 (en) * 1992-10-23 1994-05-11 Paul David Leeson Dopamine receptor subtype ligands
DE69325662T2 (de) * 1992-10-23 2000-02-10 Merck Sharp & Dohme Ltd., Hoddesdon Dopamin rezeptor subtyp liganden
CZ224195A3 (en) * 1993-03-01 1996-03-13 Merck Sharp & Dohme The use of pyrrolopyridine derivatives for preparing pharmaceutical preparations
WO1994020459A2 (en) * 1993-03-01 1994-09-15 Merck Sharp & Dohme Limited Pyrrolo-pyridine derivatives as dopamine receptor ligands
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
JPH08508466A (ja) * 1993-03-05 1996-09-10 メルク シヤープ エンド ドーム リミテツド ドーパミンｄ４リガンドとしてのキノロン誘導体
GB9416162D0 (en) * 1994-08-10 1994-09-28 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
YU63795A (sh) 1999-03-04
EP0783503A1 (en) 1997-07-16
KR100244848B1 (ko) 2000-03-02
CA2200959C (en) 2000-05-23
IL115384A (en) 1999-10-28
CA2200959A1 (en) 1996-04-11
IL115384A0 (en) 1995-12-31
UA50720C2 (uk) 2002-11-15
TR199501194A2 (tr) 1996-06-21
BR9504230A (pt) 1996-08-06
NO971416L (no) 1997-05-20
HRP950507B1 (en) 2002-06-30
EP0783503B1 (en) 2001-11-28
WO1996010571A1 (en) 1996-04-11
ES2166830T3 (es) 2002-05-01
CZ94797A3 (cs) 1998-07-15
SK32597A3 (en) 1998-09-09
HRP950507A2 (en) 1997-08-31
PE47196A1 (es) 1996-11-11
DE69524241D1 (de) 2002-01-10
SK284341B6 (sk) 2005-02-04
TW406081B (en) 2000-09-21
FI971310A (fi) 1997-03-27
PL180899B1 (pl) 2001-04-30
MY113729A (en) 2002-05-31
ATE209648T1 (de) 2001-12-15
AU681310B2 (en) 1997-08-21
CN1068327C (zh) 2001-07-11
NO971416D0 (no) 1997-03-25
KR970706282A (ko) 1997-11-03
MX9702350A (es) 1997-06-28
CN1168672A (zh) 1997-12-24
ZA958223B (en) 1997-04-01
HUT77354A (hu) 1998-03-30
CO4410335A1 (es) 1997-01-09
JP3287574B2 (ja) 2002-06-04
AU3189395A (en) 1996-04-26
RU2163239C2 (ru) 2001-02-20
DE69524241T2 (de) 2002-06-13
FI971310A0 (fi) 1997-03-27
PT783503E (pt) 2002-03-28
CZ285090B6 (cs) 1999-05-12
PL319636A1 (en) 1997-08-18
DK0783503T3 (da) 2002-02-11
NO308995B1 (no) 2000-11-27
JPH09511527A (ja) 1997-11-18
US5852031A (en) 1998-12-22
FI113655B (fi) 2004-05-31
NZ290936A (en) 1998-01-26

Similar Documents

Publication Publication Date Title
TWI751585B (zh) 類升糖素肽1受體促效劑
EP2755967B1 (en) Heterocyclic compounds for the treatment of cystic fibrosis
EP2225227B1 (de) 1',3'-Dihydrospiro[imidazolidin-4,2'-inden]-2,5-dione und 1,3-dihydrospiro[inden-2,3']-pyrrole als CGRP Antagonisten
EP2386558B1 (de) CGRP-Antagonisten
KR102455518B1 (ko) ＲＯＳ1 저해제로서 치환된 4,5,6,7-테트라히드로피라졸로[1,5-ａ]피리미딘 유도체 및 2,3-디히드로-1Ｈ-이미다조[1,2-ｂ]피라졸 유도체
EP3679039B1 (en) Tyrosine analogues derivatives as rho- kinase inhibitors
JP7213193B2 (ja) Ｎｉｋ阻害剤としての新規の置換アザインドリン誘導体
SI9520096A (sl) Derivati 2,7-substituiranega oktahidro-1H-pirido /1,2-a/ pirazina
CN112752757A (zh) 作为rho-激酶抑制剂的酪氨酸酰胺衍生物
CN115380032A (zh) 用于治疗认知障碍的kv3增强剂
US20030055061A1 (en) 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US20120083489A1 (en) Bis-pyridylpyridones as melanin-concentrating hormone receptor antagonists
US20120077795A1 (en) Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
BG103685A (bg) Хиноксалиндиони
CN113227100A (zh) 噻吩并吡啶酮化合物
EP2065386A1 (de) CGRP Antagonisten
RU2780577C2 (ru) Новые замещенные производные азаиндолина в качестве ингибиторов nik
WO2024062089A1 (en) Pcsk9 inhibitors and methods of use thereof
EP4303215A1 (en) Glp-1 receptor agonist, pharmaceutical composition comprising same, and method for preparing same
MXPA00006403A (es) Derivados 2,7-sustituidos de octahidro-1h-pirido[1,2-a]pirazina

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20070125